ComplianceWire® Solutions to FDA Pharma Company Observations

The experts at UL Solutions ComplianceWire^® are in the business of helping you mitigate risk by supporting your critical areas with effective training programs. This will help prepare your company to be audit-ready for a U.S. Food and Drug Administration (FDA) or other agency inspection at any time. To support your success, UL Solutions subject matter experts have reviewed the FDA’s audit observations from field audits of pharmaceutical companies conducted from 2013 to 2022 and summarized the 26 most cited areas. 

We then mapped our ComplianceWire^® content catalog offerings to these areas of focus from the FDA to produce the resulting document. By implementing these e-learning courses into your training programs annually or more frequently, you can have confidence that you are providing the necessary training requirements in areas where the FDA has focused in the past.